HK1206972A1 - Microparticle vaccine against malaria - Google Patents

Microparticle vaccine against malaria

Info

Publication number
HK1206972A1
HK1206972A1 HK15107495.8A HK15107495A HK1206972A1 HK 1206972 A1 HK1206972 A1 HK 1206972A1 HK 15107495 A HK15107495 A HK 15107495A HK 1206972 A1 HK1206972 A1 HK 1206972A1
Authority
HK
Hong Kong
Prior art keywords
vaccine against
against malaria
microparticle vaccine
microparticle
malaria
Prior art date
Application number
HK15107495.8A
Other languages
English (en)
Chinese (zh)
Inventor
Thomas J Powell
Original Assignee
Artificial Cell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artificial Cell Technologies Inc filed Critical Artificial Cell Technologies Inc
Publication of HK1206972A1 publication Critical patent/HK1206972A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15107495.8A 2012-03-30 2015-08-04 Microparticle vaccine against malaria HK1206972A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261617998P 2012-03-30 2012-03-30
PCT/US2013/033070 WO2013148426A1 (en) 2012-03-30 2013-03-20 Microparticle vaccine against malaria

Publications (1)

Publication Number Publication Date
HK1206972A1 true HK1206972A1 (en) 2016-01-22

Family

ID=48050943

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107495.8A HK1206972A1 (en) 2012-03-30 2015-08-04 Microparticle vaccine against malaria

Country Status (13)

Country Link
US (1) US9433671B2 (ko)
EP (1) EP2830653B1 (ko)
JP (1) JP6335876B2 (ko)
CN (1) CN104244971B (ko)
AU (1) AU2013240105B2 (ko)
BR (1) BR112014024374B1 (ko)
CA (1) CA2868450C (ko)
DK (1) DK2830653T3 (ko)
ES (1) ES2885806T3 (ko)
HK (1) HK1206972A1 (ko)
IL (1) IL234694B (ko)
MX (1) MX350709B (ko)
WO (1) WO2013148426A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018628A1 (en) 2010-07-26 2012-02-09 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9974850B2 (en) 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
WO2017048689A1 (en) * 2015-09-16 2017-03-23 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2017075053A1 (en) * 2015-10-26 2017-05-04 Cour Pharmaceuticals Development Company Inc. Immune-modifying particles for the treatment of malaria
EP3860648A4 (en) * 2018-10-04 2022-10-19 Artificial Cell Technologies, Inc. ANTI-MALARIAL COMPOSITIONS AND METHODS
WO2024064934A1 (en) * 2022-09-23 2024-03-28 BioNTech SE Compositions for delivery of plasmodium csp antigens and related methods
WO2024063789A1 (en) * 2022-09-23 2024-03-28 BioNTech SE Compositions for delivery of malaria antigens and related methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734263B2 (ja) 1993-05-25 2006-01-11 ワイス・ホールディングズ・コーポレイション 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
AU2004244962A1 (en) 2003-04-10 2004-12-16 3M Innovative Properties Company Delivery of immune response modifier compounds using metal-containing particulate support materials
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
JP5227592B2 (ja) 2005-02-07 2013-07-03 リポテック プロプライエタリー リミテッド アジュバント物質
DE102005044400A1 (de) 2005-09-16 2007-03-22 Capsulution Nanoscience Ag Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen
DK2308900T3 (da) * 2005-10-25 2014-05-12 Artificial Cell Technologies Inc Immunogene sammensætninger og fremgangsmåder til anvendelse
EP3085373A1 (en) 2006-02-22 2016-10-26 3M Innovative Properties Company Immune response modifier conjugates
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2002847A1 (en) 2007-06-12 2008-12-17 Capsulution Nanoscience AG Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
WO2009082440A2 (en) 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
US7846824B2 (en) 2008-03-18 2010-12-07 Applied Materials, Inc. Methods for forming a titanium nitride layer
JP2012523379A (ja) * 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン 免疫原性組成物およびその使用
BR112013000345B1 (pt) 2010-07-07 2021-11-23 Artificial Cell Technologies, Inc Composição compreendendo partículas contendo epítopos de rsv
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Also Published As

Publication number Publication date
MX2014011713A (es) 2015-02-04
EP2830653B1 (en) 2021-08-11
ES2885806T3 (es) 2021-12-15
JP2015514087A (ja) 2015-05-18
AU2013240105A1 (en) 2014-10-02
DK2830653T3 (da) 2021-09-13
BR112014024374A2 (ko) 2017-06-20
IL234694A0 (en) 2014-11-30
BR112014024374B1 (pt) 2022-10-18
IL234694B (en) 2021-09-30
WO2013148426A1 (en) 2013-10-03
CN104244971A (zh) 2014-12-24
CA2868450C (en) 2021-02-23
CA2868450A1 (en) 2013-10-03
AU2013240105B2 (en) 2016-10-20
JP6335876B2 (ja) 2018-05-30
MX350709B (es) 2017-09-14
CN104244971B (zh) 2016-09-07
EP2830653A1 (en) 2015-02-04
US20130259945A1 (en) 2013-10-03
US9433671B2 (en) 2016-09-06

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
SG11201405804YA (en) Vaccine against rsv
HK1212906A1 (zh) 疫苗組合物
ZA201508642B (en) Malaria vaccine
HK1206972A1 (en) Microparticle vaccine against malaria
EP2876161A4 (en) VACCINE
GB201223386D0 (en) Vaccine
GB201318084D0 (en) Malaria vaccination
HK1212919A1 (zh) 疫苗
ZA201403950B (en) Vaccine for falciparum malaria
ZA201404512B (en) Malaria vaccine
ZA201405107B (en) Mtb-c vaccine against asthma
EP2822599A4 (en) VACCINE
EP3043815A4 (en) Malaria vaccine
GB201202090D0 (en) Vaccine
EP2894366A4 (en) SHOCK ABSORBING LINK
HK1206272A1 (en) Vaccine against rsv rsv
DK2846829T3 (en) Vaccine combinations
GB201217321D0 (en) Vaccine
GB201210226D0 (en) Vaccine
GB201206169D0 (en) Vaccine
GB201205599D0 (en) Vaccine
AP2014007732A0 (en) Vaccine for falciparum malaria